De. Gannett et al., THE ROLE OF POSTOPERATIVE IRRADIATION IN THE TREATMENT OF OLIGODENDROGLIOMA, International journal of radiation oncology, biology, physics, 30(3), 1994, pp. 567-573
Citations number
36
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: Controversy regarding the role of adjuvant radiation therapy
for the treatment of oligodendroglioma continues to exist. To better d
efine the utility of postoperative irradiation for this tumor, the exp
erience at the University of Washington was retrospectively examined.
Methods and Materials: The histologic samples of 63 patients given the
diagnosis of oligodendroglioma were reviewed by a panel of neuropatho
logists and 41 were classified as pure oligodendroglioma. The two trea
tment groups included 14 patients treated with surgery only and 27 who
received surgery and postoperative radiation and were analyzed using
univariate and multivariate analysis with respect to prognostic factor
s, freedom from relapse, and survival. Results: Univariate statistical
analysis of 14 clinical variables showed that a poorer prognosis was
associated in patients with high cell density (p = .008), necrosis (p
= .017), hemiparesis (p = .026), and papilledema (p =.091), while pati
ents presenting with seizures had a better prognosis (p = .0096). Mult
ivariate analysis showed necrosis (p = .001) and hemiparesis (p = .02)
to be associated with decreased survival. Multivariate and univariate
analysis of the treatment groups found them to be homogenous with res
pect to prognostic factors. Survival times were significantly longer i
n the group treated with postoperative irradiation (median survival ti
me 84 vs. 47 months, p = .032). The 5 and 10 year survival rates were
83% and 46%, respectively, for the irradiated patients compared with 5
1% and 36% for those treated with surgery alone. Freedom from tumor re
currence times were also longer in irradiated patients (median relapse
free time 79 vs. 42 months, p = .01). Conclusion: Based on the result
s of this study, we recommend continuing the practice of treating olig
odendroglioma with postresection irradiation until a prospective multi
center clinical trial is conducted to thoroughly evaluate the role of
postoperative irradiation in the treatment of this tumor.